Untreated presbyopia is one of the main issues that will have a significant limiting effect on the global myopia and presbyopia market. Many individuals still don't understand the aetiology of presbyopia, which leads to delayed diagnoses and less adoption of myopia and presbyopia treatment services
NEWARK, Del, July 01, 2022 (GLOBE NEWSWIRE) -- The global myopia and presbyopia treatment market is set to witness an impressive growth rate of 8.5% over the forecasted years of 2022 to 2032. The myopia and presbyopia treatment market size is anticipated to reach a valuation of around US$ 40.5 Billion by the end of year 2032 from the current valuation of US$ 17.9 Billion in 2022.
According to the ‘World Report on Vision 2019’ issued by the World Health Organization, the yearly global costs of productivity losses linked with vision impairment from untreated myopia alone were projected to be US$ 244 Billion. In comparison to the preceding five years, the prevalence of myopia has climbed from 1.4% to 3% as revealed by myopia and presbyopia treatment market analysis report in 2020. As an inference, given the increase in myopia instances, the overall myopia and presbyopia treatment market is anticipated to rise rapidly over the next years.
Increasing government funding for conditions that cause visual impairment could help myopia and presbyopia treatment market size develop more broadly during the projected period. Additionally, the ability to prevent significant health problems including glaucoma, cataracts, and retinal damage if the condition is identified and treated early enough is also expected to fuel the expansion of the worldwide myopia and presbyopia treatment market during the projection period.
Request for PDF Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15118
The myopia and presbyopia market growth is favored due to the rapid improvement in the treatment procedures and the expansion of eye clinics. Increase in the prevalence of visual impairments and brought on by these disorders and are observed to be boosting the global myopia and presbyopia treatment market share.
Higher use of contact lenses among the younger generation of present age, as well as surgical alternatives across the countries have boosted the myopia and presbyopia treatment business significantly. Furthermore, the myopia and presbyopia treatment market opportunities is expanding as a consequence of technological introductions, an increase in optometrists, and rising consumer knowledge of available treatment alternatives.
Key Takeaways from Myopia and Presbyopia Treatment Market Study
The overall growth of the global myopia and presbyopia treatment market is estimated to be around US$ 20.6 Billion over the forecasted years of 2022 to 2032 by following the average CAGR of 8.5%.
The net worth of the myopia and presbyopia treatment market size is predicted to reach around a valuation of US$ 40.5 Billion by the end of the year 2032.
In the myopia treatment market segment, the single prescription treatment is the dominating category of the overall market with revenue share of more than 30% generated globally.
In the presbyopia treatment category, the prescription lenses segment holds the largest share of more than 25% of the revenue generated globally.
Among the broad geographical regions, US myopia and presbyopia treatment market leads the target market with a strong foundation and infrastructure for the technological innovations pertaining to ocular treatment.
Feel Free to Ask Your Queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-15118
Some of the well-known myopia and presbyopia treatment market players are Ziemer Ophthalmic Systems AG, NIDEK CO., LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated, Haag-Streit UK, and Topcon Corporation among others.
Recent Developments in the Global Myopia and Presbyopia Treatment Market:
CooperVision began the Take Control: Myopia & You education campaign in October 2021 with the goal of raising attention and inspiring parents to seek eye checkups for their kids mostly in United States.
The Max orthokeratology lens from Euclid Systems Corp. was introduced in June 2021 that is intended to momentarily decrease myopia incidences.
Myopia and Presbyopia Treatment Market by Segmentation
By Myopia Treatment Type:
By Presbyopia Treatment Type:
Middle East and Africa
Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-15118
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
Have a Look at Related Research Reports of Healthcare Domain
Medical Germicidal Lamps Market Size: The medical germicidal lamps market is anticipated to be US$ 560.5 Million by 2032, up from US$ 215.8 Million in 2022, advancing at a CAGR of 9.1% from 2022 to 2032.
Membrane Filter Cartridge Market Share: As per FMI Analysts, the global Membrane filter cartridge market is estimated to be valued at US$ 2042 Million in 2022 and is projected to increase at a CAGR of 4.5% in the forecast period from 2022 to 2032.
Aflatoxicosis Treatment Market Outlook: As per the analysis, the global aflatoxicosis treatment market is expected to secure US$ 403.5 Million from 2022 to 2032, while recording a CAGR of 3.8% during the prior mentioned time period.
Medical Cyclotron Market Overview: The medical cyclotron market is likely to expand its market roots in the global market at a promising CAGR of 9.6% during the forecast period. The global market holds a projected revenue of US$ 205.3 Mn in 2022, and this value is expected to cross US$ 562.4 Mn by the end of 2032.
Hemostats For Wound Closure Market Trends: The Hemostats For Wound Closure Market expected to register a CAGR of 6.3% during the forecast period, up from US$ 2.4 Bn in 2021 to reach a valuation of US$ 3.5 Bn by 2026.
Coronavirus Immunoassay Market Growth: The global coronavirus immunoassay market reached US$ 3.7 Bn in 2021. With sales growing at a 5.5% CAGR over the assessment period, the market size is projected to surpass US$ 6.9 Bn by 2032. Immunoassay kits & reagents are leading the market with a share of about 64.0% in the year 2021.
Heart Block Therapeutics Market Demand: The market is expected to reach a worth of about US$ 4.8 Bn by the end of 2032, with a projected CAGR of 4.3% during 2022 – 2032. During 2015 to 2021, the Heart Block Therapeutics Market experienced a growth of 4.9%.
Smart Pill Technologies Market Forecast: The smart pill technologies market is projected to record a CAGR of 21% during the forecast period, up from US$ 627.1 Mn in 2020 to reach a valuation of US$ 6176 Mn by 2032.
Immunochemistry Products Market Value: The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.
Biomedical Refrigerators and Freezers Market Volume: The biomedical refrigerators and freezers market is projected to record a CAGR of 5.9% during the forecast period, up from US$ 3.2 Bn in 2020 to reach a valuation of US$ 6 Bn by 2031.
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
For Sales Enquiries: firstname.lastname@example.org
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs